Evidence map›Paper›PMID 41959538›Full record

ArticlebioRxiv : the preprint server for biology2026

Carbapenem-resistant

Kyle D Buchan, Jesus M Duran Ramirez, Jana Gomez, Timothy R Cruz, Ender Volkan, Micaela N Sandoval, Allyson E Shea, Jennifer N Walker, Blake M Hanson

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kyle D BuchanCenter for Infectious Diseases, UTHealth Houston School of Public Health, UTHealth Houston, Houston, TX.ORCID 0000-0002-1934-3287
Jesus M Duran RamirezDepartment of Microbiology & Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX.ORCID 0000-0003-0907-0550
Jana GomezDepartment of Microbiology & Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX.ORCID 0000-0002-3960-9636
Timothy R CruzCenter for Infectious Diseases, UTHealth Houston School of Public Health, UTHealth Houston, Houston, TX.
Ender VolkanDepartment of Basic and Clinical Sciences, University of Nicosia Medical School, 2414, Nicosia, Cyprus.ORCID 0000-0002-0071-5028
Micaela N SandovalCenter for Infectious Diseases, UTHealth Houston School of Public Health, UTHealth Houston, Houston, TX.ORCID 0000-0002-0777-3933
Allyson E SheaDepartment of Microbiology and Immunology, University of South Alabama, Mobile, AL.ORCID 0000-0003-1329-3888
Jennifer N WalkerCenter for Infectious Diseases, UTHealth Houston School of Public Health, UTHealth Houston, Houston, TX.ORCID 0000-0002-0079-3261
Blake M HansonCenter for Infectious Diseases, UTHealth Houston School of Public Health, UTHealth Houston, Houston, TX.ORCID 0000-0003-2949-7818

Funding

Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SAVIDGE, TOR C. · 2020 to 2025
$12.0M
Defining Host-pathogen Interactions in CAUTI to Guide Novel Drug DevelopmentK01DK128381 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Jennifer Nicole Walker · 2022 to 2026
$691k
NIAID NIH HHS P01 AI152999NIDDK NIH HHS K01 DK128381
6 · The paper itself

Abstract

Carbapenem-resistant (CR)

Identifiers

PMID41959538
PMCPMC13060141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.